ICLR Latest Headlines

SUNFLOWER Lupus Trial Puts AstraZeneca and ICON in Focus for Long-Term Investors

at www.tipranks.com (Tue, 2-Jun 12:31 PM)

Analyst Maintains Buy on ICON as Accounting Overhang Clears and Long-Term Earnings Growth Outlook Remains Intact

at www.tipranks.com (Tue, 2-Jun 7:52 AM)

ICLR Delivers Strong Bookings and Enhanced Backlog Visibility Amid Internal Audit Reforms

Market Chameleon (Thu, 28-May 11:54 AM)

ICLR Investigation Concludes with Minimal Revenue Overstatement—Restatements Announced, Focus Shifts to Forward Growth

Market Chameleon (Wed, 29-Apr 11:47 AM)

ICON Audit Committee Finds Revenue Overstatement Below 2%—Restatement Process Nears Conclusion

Market Chameleon (Wed, 29-Apr 7:58 AM)